LYON, France--(BUSINESS WIRE)--BioNet Europe, the French subsidiary of BioNet, a vaccine manufacturer specializing in the development of genetically engineered vaccines, has announced the submission ...
Amy Sheng (left) is Head of the CRO Program at Sino Biological US Inc. (PA, USA), and has expertise in cell, molecular biology, immunology and biochemistry. In this interview, Amy discusses the ...
Chinese hamster ovary (CHO) cells have become one of the most popular cell type for recombinant antibody production – for good reason. CHO cells meet several key requirements for industrial scale ...
Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...
What happens when one of the world's most influential science channels spends the day exploring one of nature's most extraordinary materials?
In September 1970, Janet Mertz joined the biochemistry department at Stanford University. She was one of only six new graduate students in the department and the first female one admitted in nine ...
Please provide your email address to receive an email when new articles are posted on . According to the CDC, manufacturers expect to deliver 188 million to 200 million doses of influenza vaccine in ...
Recombinant antibodies offer clear advantages over conventional polyclonal and hybridoma-derived antibodies by providing sequence-defined, renewable, and highly reproducible reagents. Their use ...
insights from industryDr. Tillman ZiegertManaging DirectorBiorbyt Ltd. In this interview, News-Medical speaks to Dr. Tillmann Ziegert, Managing Director at Biorbyt Ltd., about the balance between ...
insights from industryAmy ShengHead of CROSino Biological In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO program at Sino Biological US Inc., about current developments in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results